Hy Isenbaum

Director/Board Member at Lunenfeld-Tanenbaum Research Institute

Health Technology

Commercial Services

Consumer Services

Profile

Hy Isenbaum is the Founder of Soberman, Isenbaum and Colomby and served as its Managing Partner until 1993.
He served as Chairman of Bioniche Life Sciences, Inc. until May 9, 2008.
He is a past Chairman of the Board of the Mount Sinai Hospital in Toronto and was appointed by the Ontario Ministry of Health as Ombudsman to the Medical Review Committee of the College of Physicians and Surgeons.
Currently, he serves on the Board of Directors of the Samuel Lumenfeld Research Institute in Toronto and is a Governor of the Weizman Institute of Science in Israel.
Mr. Isenbaum is a Chartered Accountant.

Hy Isenbaum active positions

Companies	Position	Start
Lunenfeld-Tanenbaum Research Institute Lunenfeld-Tanenbaum Research Institute Miscellaneous Commercial ServicesCommercial Services Lunenfeld-Tanenbaum Research Institute engages in the provision of biomedical research services. It conducts research into various forms of cancer including colon, breast, pancreatic, prostate, neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine, and systems biology. The company was founded in 1985 and is headquartered in Toronto, Canada.	Director/Board Member	-
Weizmann Institute of Science	Corporate Officer/Principal	09/07/2009

All active positions of Hy Isenbaum

Former positions of Hy Isenbaum

Companies	Position	End
TELESTA THERAPEUTICS INC	Chairman	09/05/2008

See the detail of Hy Isenbaum's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hy Isenbaum's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Telesta Therapeutics, Inc. Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada.	Health Technology
Lunenfeld-Tanenbaum Research Institute Lunenfeld-Tanenbaum Research Institute Miscellaneous Commercial ServicesCommercial Services Lunenfeld-Tanenbaum Research Institute engages in the provision of biomedical research services. It conducts research into various forms of cancer including colon, breast, pancreatic, prostate, neurological disorders and brain illnesses, women's and infants' health, diabetes, developmental biology, stem cell biology and tissue regeneration, mouse models of human disease, genomic medicine, and systems biology. The company was founded in 1985 and is headquartered in Toronto, Canada.	Commercial Services